Site Search

... groups such as minorities, women, and older adults. This disparity not only hampers the relevance of study findings but also perpetuates health care inequities, as treatments may not be equally effective across diverse populations. “Everyone should have a fair and just opportunity to ... ACS CAN looks forward to seeing Gov. Pritzker sign this legislation into law so Illinois can take this significant step towards improving health outcomes." 1 1 Cancer Advocates Look Forward to Seeing the Governor Sign Legislation Ensuring More Diversity in Clinical Trials Cancer ...

... who are alive now that will die prematurely due to smoking-related disease. It is the single largest preventable cause of death. The annual health care costs in Delaware directly caused by smoking are $532 million.  “Increasing the sale age for tobacco products to 21, or Tobacco 21, is a ... thank Governor Carney and bill sponsor Townsend for their support and look forward to working with our leaders to save lives and protect the health of Delaware’s young people.” 0 ACS CAN Supports Measure to Protect Delaware’s Young People from the Dangers of Tobacco ...

... has made life harder for many New Jerseyans.  They don't need their insurance carrier to make them jump through hoops before they can get the care their doctor prescribes. @NJSenatePres and @NelliePou must support S3051 and #ReformStepNJ. The practice of step therapy has grown ... to a vote. Reforming step therapy means ensuring that it is ✔ safe for patients ✔ clinically grounded, and ✔ transparent to patients and health care providers. #ReformStepNJ We need @NJSenatePres and @NelliePou to bring S3051 to a vote. Fail first policies can result in patients not ... these plans. @NJSenatePres and @NelliePou must pass S3051 #ReformStepNJ In an analysis of coverage decisions for 17 of the 20 largest commercial health insurers in the U.S., it was found that ALL insurers used step therapy to restrict access to drugs, ranging from 2% to 49% of coverage ...

... received the three lifechanging words “you have cancer” and around 32,230 died from the disease. Innovation in early detection and cancer care are changing how we detect and treat cancer, but these staggering incidence and mortality rates suggest that many New Yorkers aren’t ... increasingly important for the treatment of other diseases, including arthritis, other autoimmune conditions and rare diseases. Currently, many health insurance plans in New York, including Medicaid, may not cover the most appropriate biomarker testing for all patients who could benefit, ... tested for certain guideline-indicated biomarkers. With biomarker testing increasingly becoming a standard of care in oncology, it’s time that health insurance plans keep up with innovations in testing and treatment. Improving access to biomarker is a simple way for legislators in Albany ...